The OS analysis (Supplementary Figure S1A) revealed that high PPARG expression was associated with poor prognosis in lower-grade glioma and glioblastoma (GBMLGG), lower-grade glioma (LGG), glioblastoma (GBM), LIHC, THCA, PAAD, and ALL-R. Here, PPARG is linked to central nervous system cancer.